Back
MercadoLibre Vs. Akero Therapeutics Industry Stock Comparison
Sell
50
MELI
MercadoLibre
Last Price:
$1,921.19
Seasonality Move:
14.78%
Buy
59
AKRO
Akero Therapeutics
Last Price:
$54.05
Seasonality Move:
-13.54%
Sell
50
MercadoLibre (MELI)
is a Sell
Is MercadoLibre a Buy, Sell or Hold?
-
The current MercadoLibre [MELI] share price is $1,922.19. The Score for MELI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
MELI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $54.08. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MELI Stock Price Chart
What is MercadoLibre's stock price today?
-
The MercadoLibre share price today is $1,922.19Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MELI is experiencing selling pressure, which indicates risk of future bearish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $54.08Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight selling pressure.
MELI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 23.96 | Buy |
Relative Strength Index (14 RSI): | 61.63 | Buy |
Chaikin Money Flow: | -243156 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1739.34 - 1870.44) | Buy |
Bollinger Bands (100): | (1815.4 - 2073.72) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.25 | Buy |
Relative Strength Index (14 RSI): | 82.91 | Buy |
Chaikin Money Flow: | -280479 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.47 - 42.61) | Buy |
Bollinger Bands (100): | (24.31 - 36.07) | Buy |
MELI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1873.93 | Buy |
20-day SMA: | 1824.93 | Buy |
50-day SMA: | 1853.1 | Buy |
200-day SMA: | 1820.24 | Buy |
8-day EMA: | 1884.21 | Buy |
20-day EMA: | 1845.15 | Buy |
50-day EMA: | 1856.46 | Buy |
200-day EMA: | 1813.26 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 43 | Buy |
20-day SMA: | 32.36 | Buy |
50-day SMA: | 31 | Buy |
200-day SMA: | 26.7 | Buy |
8-day EMA: | 45.65 | Buy |
20-day EMA: | 36.88 | Buy |
50-day EMA: | 32.36 | Buy |
200-day EMA: | 28.76 | Buy |
MercadoLibre Earnings Growth & MELI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.30 per share, and an increase next year of $18.40 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.10 per share.
MercadoLibre Technical Analysis
Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Jan 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Jan 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |